Hospital Statistics for Mesothelioma
Hospitalization and Mesothelioma
Hospitals & Clinics: Mesothelioma
Research hospital quality ratings and patient safety measures
for medical facilities in specialties related to Mesothelioma:
Hospital & Medical Clinic quality ratings » »
Finding the Best Hospital:
More general hospital information, not necessarily directly in relation to Mesothelioma,
on hospital performance and surgical care quality:
Hospital statistics for Mesothelioma:
The following statistics related to hospitals and hospitalization and Mesothelioma:
- 8.5 days was the mean length of stay in hospitals for mesothelioma in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 5 days was the median length of stay in hospitals for mesothelioma in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 66 was the mean age of patients hospitalised for mesothelioma in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 25% of hospital consultant episodes for mesothelioma occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 24% of hospital consultant episodes for mesothelioma occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 25% of hospital consultant episodes for mesothelioma were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 0.045% (23,559) of hospital bed days were for mesothelioma in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 0.0004% (49) of hospital consultant episodes were for benign neoplasm of mesothelial tissue in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 88% of hospital consultant episodes for benign neoplasm of mesothelial tissue required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 76% of hospital consultant episodes for benign neoplasm of mesothelial tissue were men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 24% of hospital consultant episodes for benign neoplasm of mesothelial tissue were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 40% of hospital consultant episodes for benign neoplasm of mesothelial tissue required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 9.9 days was the mean length of stay in hospitals for benign neoplasm of mesothelial tissue in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 6 days was the median length of stay in hospitals for benign neoplasm of mesothelial tissue in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 61 was the mean age of patients hospitalised for benign neoplasm of mesothelial tissue in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 41% of hospital consultant episodes for benign neoplasm of mesothelial tissue occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 29% of hospital consultant episodes for benign neoplasm of mesothelial tissue occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 10% of hospital consultant episodes for benign neoplasm of mesothelial tissue were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 0.0007% (353) of hospital bed days were for benign neoplasm of mesothelial tissue in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
Lung Cancer, the leading cause of cancer death for both men and women in the US, will be diagnosed in over 169,000 people this year. Avoiding tobacco...
Clinical trials are important to the development of new lung cancer treatments. How can they help you?
Doctors are finding that some patients with advanced non-small cell lung cancer may benefit from radiation, chemotherapy and/or newer treatment...
When lung cancer spreads to the bone it can cause severe pain and weak bones. Learn how these bone complications can be treated and even prevented,...
See full list of 7 related videos
» Next page: Articles about Mesothelioma
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards:
